The DEEP project has received research funding from the European Union under the 7th Framework Programme

clinical trials

DEEP-2 Investigator Meeting

agosto 14, 2016
|
Comments off
|

The last DEEP-2 Investigator Meeting was organised on April 14th 2016 in the framework of the 7th DEEP General Assembly in Padua. It was designed as a guided roundtable where CRAs and Principal Investigators from main recruiting sites had the opportunity to depict the situation at their […]

Share
Read more →

DEEP-2 study completed the enrollment!

agosto 14, 2016
|
Comments off
|

A big project milestone has been reached as the last few patients have been randomized. Thanks to the last achievements and efforts made by the PIs to recruit patients, the DEEP-2 Study has finally completed the enrollment.

The last patients were included […]

Share
Read more →

DEEP-2: an update of the clinical centres involved

ottobre 30, 2015
|
Comments off
|

Another step forward has been made toward the enrollment of new patients in the DEEP-2 study, a phase III multicentre, randomised, open label, non-inferiority active-controlled trial aiming at comparing for the first time the efficacy of deferiprone (DFP) vs deferasirox (DFX) in paediatric patients affected […]

Share
Read more →

The Story of the project as described in the Scientific report to the EC

ottobre 30, 2015
|
Comments off
|

The most important achievements and activities carried out by the project have been collected and included in the DEEP Scientific Report related to the period from 01/01/2014 to 30/06/2015 which has been submitted to the European Commission on September 2015.

The report provided a […]

Share
Read more →